View Past PerformanceThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsC-Lab 대차대조표 건전성재무 건전성 기준 점검 6/6C-Lab 의 총 주주 지분은 ₪74.5M 이고 총 부채는 ₪0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 ₪99.1M 및 ₪24.6M 입니다.핵심 정보0%부채/자본 비율₪0부채이자보상배율n/a현금₪38.02m자본₪74.46m총부채₪24.65m총자산₪99.11m최근 재무 건전성 업데이트업데이트 없음모든 업데이트 보기Recent updates분석 기사 • Jan 22C-Lab Ltd's (TLV:CLAB) 27% Price Boost Is Out Of Tune With RevenuesC-Lab Ltd ( TLV:CLAB ) shares have continued their recent momentum with a 27% gain in the last month alone. But the...분석 기사 • Jan 15Calculating The Fair Value Of C-Lab Ltd (TLV:CLAB)Key Insights Using the 2 Stage Free Cash Flow to Equity, C-Lab fair value estimate is ₪12.10 With ₪11.70 share price...New Risk • Jan 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (₪99.2m market cap, or US$31.4m).공시 • Jan 13C-Lab Ltd, Annual General Meeting, Feb 16, 2026C-Lab Ltd, Annual General Meeting, Feb 16, 2026. Location: co. offices, IsraelBuy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 5.5% to ₪9.55. The fair value is estimated to be ₪12.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Nov 12C-Lab Ltd's (TLV:CLAB) Business Is Trailing The Industry But Its Shares Aren'tThere wouldn't be many who think C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x is worth a mention...Buy Or Sell Opportunity • Sep 16Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₪9.38. The fair value is estimated to be ₪12.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.분석 기사 • Aug 08Investors Could Be Concerned With C-Lab's (TLV:CLAB) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...분석 기사 • Jun 24C-Lab Ltd's (TLV:CLAB) Share Price Could Signal Some RiskIt's not a stretch to say that C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x right now seems quite...Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.New Risk • Mar 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (₪107.5m market cap, or US$29.7m).분석 기사 • Dec 09Cautious Investors Not Rewarding C-Lab Ltd's (TLV:CLAB) Performance CompletelyC-Lab Ltd's ( TLV:CLAB ) price-to-earnings (or "P/E") ratio of 6.3x might make it look like a strong buy right now...공시 • Dec 06C-Lab Ltd, Annual General Meeting, Jan 09, 2025C-Lab Ltd, Annual General Meeting, Jan 09, 2025. Location: co. offices, IsraelBoard Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Yanir Farber was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to ₪10.60, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 38% over the past three years.분석 기사 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...분석 기사 • Mar 22C-Lab Ltd's (TLV:CLAB) Shares Leap 26% Yet They're Still Not Telling The Full StoryDespite an already strong run, C-Lab Ltd ( TLV:CLAB ) shares have been powering on, with a gain of 26% in the last...분석 기사 • Mar 21Why The 23% Return On Capital At C-Lab (TLV:CLAB) Should Have Your AttentionDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪145.7m market cap, or US$39.8m).Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪17.18, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Tech industry in Asia. Total returns to shareholders of 10% over the past three years.New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪119.4m market cap, or US$32.9m).Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₪13.57, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 19% over the past year.분석 기사 • Dec 07We Like These Underlying Return On Capital Trends At C-Lab (TLV:CLAB)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₪129.5m market cap, or US$34.1m).분석 기사 • Aug 06C-Lab's (TLV:CLAB) Returns On Capital Are Heading HigherIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...분석 기사 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪16.81, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 15x in the Tech industry in Asia. Negligible returns to shareholders over past year.분석 기사 • Mar 25Returns On Capital Are Showing Encouraging Signs At C-Lab (TLV:CLAB)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.공시 • Oct 03CompuLab Ltd. (TASE:CLAB) announces an Equity Buyback for ILS 1 million worth of its shares.CompuLab Ltd. (TASE:CLAB) announces a share repurchase program. Under the program, the company will repurchase up to ILS 1 million worth of its shares. The repurchases will be funded from company's cash balance. The plan will be valid till October 2, 2023.분석 기사 • May 25Returns On Capital At CompuLab (TLV:CLAB) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Shai Tsabari was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.분석 기사 • May 25Optimistic Investors Push CompuLab Ltd. (TLV:CLAB) Shares Up 30% But Growth Is LackingCompuLab Ltd. ( TLV:CLAB ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₪20.06, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 20x in the Tech industry in Asia.Reported Earnings • Mar 24Full year 2020 earnings released: EPS ₪1.35 (vs ₪0.64 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₪105.3m (down 1.8% from FY 2019). Net income: ₪11.5m (up 110% from FY 2019). Profit margin: 11% (up from 5.1% in FY 2019). The increase in margin was driven by lower expenses.재무 상태 분석단기부채: CLAB 의 단기 자산 ( ₪78.8M )이 단기 부채( ₪23.8M ).장기 부채: CLAB의 단기 자산(₪78.8M)이 장기 부채(₪859.0K)를 초과합니다.부채/자본 비율 추이 및 분석부채 수준: CLAB 부채가 없습니다.부채 감소: CLAB는 5년 전 부채 대비 자본 비율이 16%였으나 현재 부채가 없습니다.부채 범위: CLAB 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.이자 보장: CLAB 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.대차대조표건전한 기업 찾아보기7D1Y7D1Y7D1YTech 산업의 건실한 기업.View Dividend기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/02/11 16:35종가2026/02/03 00:00수익2025/06/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스C-Lab Ltd는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
분석 기사 • Jan 22C-Lab Ltd's (TLV:CLAB) 27% Price Boost Is Out Of Tune With RevenuesC-Lab Ltd ( TLV:CLAB ) shares have continued their recent momentum with a 27% gain in the last month alone. But the...
분석 기사 • Jan 15Calculating The Fair Value Of C-Lab Ltd (TLV:CLAB)Key Insights Using the 2 Stage Free Cash Flow to Equity, C-Lab fair value estimate is ₪12.10 With ₪11.70 share price...
New Risk • Jan 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Market cap is less than US$100m (₪99.2m market cap, or US$31.4m).
공시 • Jan 13C-Lab Ltd, Annual General Meeting, Feb 16, 2026C-Lab Ltd, Annual General Meeting, Feb 16, 2026. Location: co. offices, Israel
Buy Or Sell Opportunity • Dec 17Now 21% undervaluedOver the last 90 days, the stock has risen 5.5% to ₪9.55. The fair value is estimated to be ₪12.01, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Nov 12C-Lab Ltd's (TLV:CLAB) Business Is Trailing The Industry But Its Shares Aren'tThere wouldn't be many who think C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x is worth a mention...
Buy Or Sell Opportunity • Sep 16Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₪9.38. The fair value is estimated to be ₪12.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.9% over the last 3 years. Meanwhile, the company became loss making.
분석 기사 • Aug 08Investors Could Be Concerned With C-Lab's (TLV:CLAB) Returns On CapitalTo find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
분석 기사 • Jun 24C-Lab Ltd's (TLV:CLAB) Share Price Could Signal Some RiskIt's not a stretch to say that C-Lab Ltd's ( TLV:CLAB ) price-to-sales (or "P/S") ratio of 1.1x right now seems quite...
Reported Earnings • Mar 27Full year 2024 earnings released: EPS: ₪0.34 (vs ₪2.42 in FY 2023)Full year 2024 results: EPS: ₪0.34 (down from ₪2.42 in FY 2023). Revenue: ₪87.7m (down 33% from FY 2023). Net income: ₪2.87m (down 86% from FY 2023). Profit margin: 3.3% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings.
New Risk • Mar 09New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (₪107.5m market cap, or US$29.7m).
분석 기사 • Dec 09Cautious Investors Not Rewarding C-Lab Ltd's (TLV:CLAB) Performance CompletelyC-Lab Ltd's ( TLV:CLAB ) price-to-earnings (or "P/E") ratio of 6.3x might make it look like a strong buy right now...
공시 • Dec 06C-Lab Ltd, Annual General Meeting, Jan 09, 2025C-Lab Ltd, Annual General Meeting, Jan 09, 2025. Location: co. offices, Israel
Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. Independent Director Yanir Farber was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 03Investor sentiment deteriorates as stock falls 33%After last week's 33% share price decline to ₪10.60, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 38% over the past three years.
분석 기사 • Mar 26Impressive Earnings May Not Tell The Whole Story For C-Lab (TLV:CLAB)C-Lab Ltd's ( TLV:CLAB ) stock was strong after they recently reported robust earnings. However, our analysis suggests...
분석 기사 • Mar 22C-Lab Ltd's (TLV:CLAB) Shares Leap 26% Yet They're Still Not Telling The Full StoryDespite an already strong run, C-Lab Ltd ( TLV:CLAB ) shares have been powering on, with a gain of 26% in the last...
분석 기사 • Mar 21Why The 23% Return On Capital At C-Lab (TLV:CLAB) Should Have Your AttentionDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Reported Earnings • Mar 21Full year 2023 earnings released: EPS: ₪2.42 (vs ₪0.82 in FY 2022)Full year 2023 results: EPS: ₪2.42 (up from ₪0.82 in FY 2022). Revenue: ₪130.0m (up 9.0% from FY 2022). Net income: ₪20.5m (up 194% from FY 2022). Profit margin: 16% (up from 5.9% in FY 2022). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
New Risk • Mar 19New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪145.7m market cap, or US$39.8m).
Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪17.18, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 24x in the Tech industry in Asia. Total returns to shareholders of 10% over the past three years.
New Risk • Mar 14New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (₪119.4m market cap, or US$32.9m).
Valuation Update With 7 Day Price Move • Jan 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₪13.57, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 23x in the Tech industry in Asia. Total loss to shareholders of 19% over the past year.
분석 기사 • Dec 07We Like These Underlying Return On Capital Trends At C-Lab (TLV:CLAB)If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
New Risk • Aug 30New major risk - Revenue and earnings growthEarnings have declined by 1.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₪129.5m market cap, or US$34.1m).
분석 기사 • Aug 06C-Lab's (TLV:CLAB) Returns On Capital Are Heading HigherIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
분석 기사 • Mar 30We Think C-Lab's (TLV:CLAB) Robust Earnings Are ConservativeC-Lab Ltd's ( TLV:CLAB ) strong earnings report was rewarded with a positive stock price move. We have done some...
Valuation Update With 7 Day Price Move • Mar 29Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₪16.81, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 15x in the Tech industry in Asia. Negligible returns to shareholders over past year.
분석 기사 • Mar 25Returns On Capital Are Showing Encouraging Signs At C-Lab (TLV:CLAB)Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Reported Earnings • Mar 25Full year 2022 earnings released: EPS: ₪0.82 (vs ₪0.14 in FY 2021)Full year 2022 results: EPS: ₪0.82 (up from ₪0.14 in FY 2021). Revenue: ₪119.3m (up 43% from FY 2021). Net income: ₪6.98m (up 493% from FY 2021). Profit margin: 5.9% (up from 1.4% in FY 2021). The increase in margin was driven by higher revenue.
공시 • Oct 03CompuLab Ltd. (TASE:CLAB) announces an Equity Buyback for ILS 1 million worth of its shares.CompuLab Ltd. (TASE:CLAB) announces a share repurchase program. Under the program, the company will repurchase up to ILS 1 million worth of its shares. The repurchases will be funded from company's cash balance. The plan will be valid till October 2, 2023.
분석 기사 • May 25Returns On Capital At CompuLab (TLV:CLAB) Paint A Concerning PictureThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Shai Tsabari was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: ₪0.14 (vs ₪1.35 in FY 2020)Full year 2021 results: EPS: ₪0.14 (down from ₪1.35 in FY 2020). Revenue: ₪83.3m (down 21% from FY 2020). Net income: ₪1.18m (down 90% from FY 2020). Profit margin: 1.4% (down from 11% in FY 2020). The decrease in margin was driven by lower revenue.
분석 기사 • May 25Optimistic Investors Push CompuLab Ltd. (TLV:CLAB) Shares Up 30% But Growth Is LackingCompuLab Ltd. ( TLV:CLAB ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
Valuation Update With 7 Day Price Move • May 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₪20.06, the stock trades at a trailing P/E ratio of 14.9x. Average trailing P/E is 20x in the Tech industry in Asia.
Reported Earnings • Mar 24Full year 2020 earnings released: EPS ₪1.35 (vs ₪0.64 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: ₪105.3m (down 1.8% from FY 2019). Net income: ₪11.5m (up 110% from FY 2019). Profit margin: 11% (up from 5.1% in FY 2019). The increase in margin was driven by lower expenses.